| Literature DB >> 35992157 |
Ryan A Williams1, Karah J Dring1, John G Morris1, Caroline Sunderland1, Mary E Nevill1, Simon B Cooper1.
Abstract
Background: School-based physical activity interventions are accessible to most adolescents and could enhance adolescent cardiometabolic health and cognition; yet the feasibility and success of school-based physical activity interventions is understudied.Entities:
Keywords: adolescence; cardiometabolic health; cognitive function; exercise training; physical activity
Year: 2022 PMID: 35992157 PMCID: PMC9390877 DOI: 10.3389/fspor.2022.884051
Source DB: PubMed Journal: Front Sports Act Living ISSN: 2624-9367
Figure 1(A) Schematic representation of the overall study design. Training session details indicate the number of sprints performed. (B) Visual representation for the timeline of measurements during experimental visit's 2 and 3. Thick dashed lines represent the timing of capillary blood samples.
Descriptive summary of baseline participant characteristics for the intervention and control groups.
|
| ||||
|---|---|---|---|---|
|
|
|
|
|
|
| Age (y) | 11.8 ± 0.2 | 11.6–12.0 | 11.6 ± 0.4 | 11.2–12.2 |
| Height (cm) | 155.3 ± 7.4 | 142.5–165.5 | 159.7 ± 7.4 | 147.9–171.7 |
| Maturity offset (y) | 0.01 ± 0.32 | −0.49–0.42 | 0.13 ± 0.52 | −0.59–1.14 |
| Body mass (kg) | 43.2 ± 8.6 | 33.8–57.4 | 47.6 ± 9.9 | 33.8–60.5 |
| BMI (kg·m−2) | 17.8 ± 2.2 | 15.0–21.6 | 18.5 ± 3.0 | 15.3–23.2 |
| BMI centile | 44.4 ± 31.7 | 5.3–89.4 | 52.9 ± 36.0 | 9.3–94.9 |
| Sum of skinfolds (mm) | 50.0 ± 17.3 | 30.2–83.5 | 58.6 ± 30.0 | 23.4–117.5 |
| Waist circumference (cm) | 61.8 ± 5.3 | 56.9–72.7 | 64.8 ± 6.2 | 57.0–74.7 |
SD, Standard Deviation; BMI, Body Mass Index.
Average external and internal training load for each session across the intervention period.
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
| 280 ± 17 (263–316) | 47 ± 3 | 6.0 ± 0.4 (5.5–6.8) | 181 ± 7 | 88 ± 4 (83–94) | 194 ± 5 | 94 ± 3 (91–100) |
|
| 252 ± 21 (215–287) | 42 ± 3 | 5.8 ± 0.3 (5.3–6.4) | 179 ± 9 | 86 ± 3 (82–91) | 193 ± 6 | 93 ± 2 (90–94) |
|
| 269 ± 19 (248–300) | 45 ± 3 | 5.8 ± 0.4 (5.3–6.4) | 177 ± 8 | 86 ± 4 (79–88) | 192 ± 4 | 93 ± 3 (89–97) |
|
| 337 ± 15 (323–367) | 42 ± 2 | 5.7 ± 0.4 (5.3–6.5) | 182 ± 7 | 88 ± 3 (82–93) | 195 ± 5 | 94 ± 3 (91–99) |
|
| 327 ± 41 (242–373) | 42 ± 2 | 5.7 ± 0.5 (5.2–6.5) | 179 ± 6 | 87 ± 3 (82–89) | 191 ± 5 | 92 ± 2 (90–94) |
|
| 329 ± 26 (302–376) | 42 ± 3 | 6.3 ± 0.5 (5.6–7.0) | 181 ± 9 | 88 ± 5 (82–96) | 194 ± 9 | 94 ± 4 (90–100) |
HR, Heart Rate; HRMax, Maximum Heart Rate.
a Maximum heart rate achieved during the multi-stage fitness test.
+n= 5 due to technical issues with GPS units.
++n= 7 due to absence from school.
Data are mean ± SD (range).
Summary of the frequencies for individual statement responses of the PACES questionnaire (n = 8).
|
|
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
| I enjoy it | 0 | 0 | 0 | 4 | 4 | 0 | 0 | 1 | 2 | 5 |
| I feel bored | 5 | 2 | 0 | 1 | 0 | 5 | 2 | 1 | 0 | 0 |
| I dislike it | 6 | 2 | 0 | 0 | 0 | 6 | 2 | 0 | 0 | 0 |
| I find it pleasurable | 0 | 0 | 2 | 5 | 1 | 0 | 0 | 2 | 4 | 2 |
| It's no fun at all | 7 | 1 | 0 | 0 | 0 | 6 | 2 | 0 | 0 | 0 |
| It gives me energy | 0 | 0 | 1 | 6 | 1 | 1 | 0 | 1 | 5 | 1 |
| It makes me depressed | 7 | 1 | 0 | 0 | 0 | 7 | 1 | 0 | 0 | 0 |
| It's very pleasant | 0 | 0 | 3 | 3 | 2 | 0 | 0 | 2 | 4 | 2 |
| My body feels good | 0 | 0 | 2 | 4 | 2 | 0 | 0 | 0 | 4 | 4 |
| I get something out of it | 0 | 0 | 1 | 4 | 3 | 0 | 0 | 0 | 3 | 5 |
| It's very exciting | 0 | 1 | 2 | 4 | 1 | 0 | 0 | 3 | 2 | 3 |
| It frustrates me | 6 | 2 | 0 | 0 | 0 | 6 | 2 | 0 | 0 | 0 |
| It's not at all interesting | 6 | 1 | 1 | 0 | 0 | 7 | 1 | 0 | 0 | 0 |
| It gives me a strong feeling of success | 0 | 0 | 2 | 5 | 1 | 0 | 0 | 1 | 3 | 4 |
| It feels good | 0 | 0 | 2 | 3 | 3 | 0 | 0 | 1 | 3 | 4 |
| I feel as though I would rather be doing something else | 6 | 2 | 0 | 0 | 0 | 0 | 5 | 3 | 0 | 0 |
Data are shown for session 1 and session 4.
Baseline and follow-up results of physical fitness and cardiometabolic health outcomes, with data presented as mean ± SD.
|
| |||||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| |
| MSFT (m) | 850 ± 323 | 1,025 ± 350 | 999 (884, 1,114) | 798 ± 367 | 873 ± 388 | 898 (783, 1,013) | 100 (−62, 263) |
| 20 m Sprint (s) | 3.77 ± 0.20 | 3.74 ± 0.25 | 3.80 (3.70, 3.89) | 3.89 ± 0.24 | 3.65 ± 0.26 | 3.59 (3.49, 3.69) | |
| Fasting blood glucose (mmol·L−1) | 4.40 ± 0.36 | 4.58 ± 0.45 | 4.68 (4.37, 4.92) | 4.60 ± 0.23 | 4.84 ± 0.32 | 4.77 (4.49, 5.04) | −0.11 (−0.49, 0.27) |
| Fasting plasma insulin (pmol·L−1) | 59.8 ± 33.9 | 46.4 ± 21.1 | 52.9 (43.6, 62.2) | 70.0 ± 22.6 | 49.7 ± 14.0 | 44.0 (35.4, 52.7) | 8.9 (−4.4, 22.1) |
| HOMA-IR (AU) | 1.96 ± 1.14 | 1.62 ± 0.81 | 1.91 (1.52, 2.29) | 2.39 ± 0.80 | 1.79 ± 0.58 | 1.54 (1.19, 1.90) | 0.36 (−0.19, 0.92) |
| Blood glucose tAUC | 726 ± 68 | 711 ± 115 | 722 (664, 779) | 750 ± 61 | 728 ± 64 | 717 (659, 774) | 5 (−75, 85) |
| Plasma insulin tAUC | 21,659 ± 6,890 | 23,685 ± 8,660 | 28,119 (22,537, 33,702) | 32,525 ± 11,059 | 29,370 ± 10,996 | 24,935 (19,352, 30,517) | 2,279 (−4,931, 9,490) |
| IL-6 (pg·ml−1) | 1.76 ± 1.90 | 1.02 ± 0.53 | 1.05 (0.61, 1.48) | 1.41 ± 1.38 | 0.82 ± 0.26 | 0.85 (0.33, 1.36) | 0.20 (−0.49, 0.89) |
| IL-10 (pg·ml−1) | 2.54 ± 0.86 | 2.55 ± 0.48 | 2.57 (2.02, 3.11) | 3.33 ± 1.72 | 2.02 ± 0.80 | 1.95 (1.44, 2.46) | 0.62 (−0.14, 1.38) |
| IL-15 (pg·ml−1) | 2.23 ± 0.65 | 2.14 ± 0.69 | 2.24 (1.48, 3.00) | 2.65 ± 0.61 | 2.82 ± 1.20 | 2.71 (1.89, 3.53) | −0.47 (−1.63, 0.69) |
| IL-1β (pg·ml−1) | 45.47 ± 37.20 | 36.6 ± 16.14 | 45.79 (29.23, 86.38) | 60.83 ± 39.10 | 52.10 ± 75.93 | 42.56 (16.84, 83.67) | 3.23 (−67.04, 73.49) |
Follow-up and between-group differences adjusted for baseline results are also presented as mean ± 95% CI.
SD, Standard Deviation; CI, Confidence Interval; MSFT, Multi-Stage Fitness Test; HOMA-IR, Homeostatic Model Assessment of Insulin Resistance; tAUC, Total area under the curve; IL, Interleukin.
aAdjusted for baseline score.
*Statistically significant difference between groups, p < 0.05.
The bolded values are statistically significant results.
Baseline and follow-up results of cognitive function outcomes, with data presented as mean ± SD.
|
| |||||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| |
|
| |||||||
| Congruent stroop | 880 ± 150 | 778 ± 131 | 764 (691, 837) | 833 ± 143 | 798 ± 113 | 811 (738, 884) | −45.7 (−148.3, 56.9) |
| Incongruent stroop | 1,224 ± 173 | 1,118 ± 194 | 1,102 (1,030, 1,175) | 1,193 ± 239 | 1,104 ± 249 | 1,119 (1,048, 1,191) | −16.5 (−118, 85) |
| Sternberg one-item | 633 ± 112 | 629 ± 150 | 600 (520, 680) | 551 ± 53 | 553 ± 61 | 583 (502, 663) | 14 (−93, 121) |
| Sternberg three-item | 819 ± 105 | 766 ± 158 | 736 (660, 813) | 746 ± 86 | 721 ± 65 | 751 (675, 827) | −12 (−116, 91) |
| Sternberg five-item | 974 ± 132 | 869 ± 152 | 831 (720, 942) | 883 ± 166 | 882 ± 214 | 920 (809, 1,031) | −81 (−234, 72) |
| Congruent flanker | 664 ± 145 | 580 ± 109 | 565 (520, 611) | 616 ± 128 | 568 ± 91 | 583 (537, 628) | −17 (−81, 47) |
| Incongruent flanker | 705 ± 147 | 620 ± 138 | 612 (547, 677) | 681 ± 149 | 633 ± 115 | 641 (576, 705) | −28 (−120, 64) |
|
| |||||||
| Congruent stroop | 97.8 ± 2.5 | 97.5 ± 3.8 | 97.7 (95.1, 100.0) | 100 ± 0 | 99.4 ± 3.5 | 99.2 (96.6, 100.0) | −1.1 (−4.4, 2.2) |
| Incongruent stroop | 97.6 ± 2.9 | 95.3 ± 4.1 | 95.1 (92.8, 97.4) | 97.2 ± 2.5 | 95.9 ± 3.5 | 96.2 (93.8, 98.5) | −1.0 (−4.0, 2.2) |
| Sternberg one-item | 98.1 ± 2.9 | 97.7 ± 3.2 | 97.6 (95.1, 100.0) | 98.4 ± 2.9 | 97.7 ± 3.2 | 97.7 (95.1, 100.0) | −0.02 (−3.6, 3.6) |
| Sternberg three-item | 96.7 ± 2.7 | 99.6 ± 1.1 | 99.6 (98.3, 100.0) | 97.3 ± 2.0 | 97.7 ± 2.2 | 97.6 (96.2, 99.0) | |
| Sternberg five-item | 94.7 ± 6.2 | 96.5 ± 3.5 | 96.6 (92.7, 100.0) | 95.7 ± 6.0 | 93.8 ± 6.3 | 93.7 (89.7, 97.6) | 2.9 (−2.6, 8.4) |
| Congruent flanker | 99.6 ± 1.2 | 99.6 ± 1.2 | 99.5 (98.6, 100.0) | 99.2 ± 1.5 | 99.6 ± 1.2 | 99.6 (98.7, 100.0) | −0.1 (−1.4, 1.1) |
| Incongruent flanker | 99.2 ± 1.54 | 96.6 ± 3.7 | 96.6 (93.2, 100.0) | 97.5 ± 3.9 | 96.7 ± 4.7 | 96.7 (93.2, 100.0) | −0.04 (−4.8, 4.7) |
| BDNF (ng·ml−1) | 18.47 ± 7.51 | 39.12 ± 9.88 | 42.9 (37.4, 48.3) | 28.69 ± 11.36 | 22.95 ± 9.13 | 19.2 (13.8, 24.7) | |
Follow-up and between-group differences adjusted for baseline results are also presented as mean ± 95% CI.
SD, Standard Deviation; CI, Confidence Interval; BDNF, Brain-Derived Neurotrophic Factor.
aAdjusted for baseline score.
*Statistically significant difference between groups, p < 0.05.
**Statistically significant difference between groups, p < 0.001.
The bolded values are statistically significant results.
Figure 2Individual (dashed) and mean (solid) pre to post brain-derived neurotrophic factor (BDNF) changes for the experimental group (A) and control group (B).